Access the full text.
Sign up today, get DeepDyve free for 14 days.
A. Zanin-Zhorov, J. Weiss, A. Trzeciak, W. Chen, Jingya Zhang, Melanie Nyuydzefe, C. Arencibia, Seetharam Polimera, O. Schueller, J. Fuentes-Duculan, Kathleen Bonifacio, Norma Kunjravia, I. Cueto, J. Soung, R. Fleischmann, A. Kivitz, M. Lebwohl, M. Nunez, Johnnie Woodson, Shondra Smith, Robert West, M. Berger, J. Krueger, J. Ryan, S. Waksal (2017)
Cutting Edge: Selective Oral ROCK2 Inhibitor Reduces Clinical Scores in Patients with Psoriasis Vulgaris and Normalizes Skin Pathology via Concurrent Regulation of IL-17 and IL-10The Journal of Immunology, 198
E. Sanchez-Lopez, J. Rodríguez-Vita, Cecile Cartier, M. Rupérez, V. Esteban, Gisselle Carvajal, R. Rodrigues-Díez, J. Plaza, J. Egido, M. Ruíz-Ortega (2008)
Inhibitory effect of interleukin-1beta on angiotensin II-induced connective tissue growth factor and type IV collagen production in cultured mesangial cells.American journal of physiology. Renal physiology, 294 1
M. Amano, K. Chihara, Kazushi Kimura, Y. Fukata, Nao Nakamura, Y. Matsuura, K. Kaibuchi (1997)
Formation of Actin Stress Fibers and Focal Adhesions Enhanced by Rho-KinaseScience, 275
Yabing Mu, Shyam Gudey, M. Landström (2011)
Non-Smad signaling pathwaysCell and Tissue Research, 347
M. Takemoto, N. Asker, H. Gerhardt, A. Lundkvist, B. Johansson, Y. Saito, C. Betsholtz (2002)
Technical Advance A New Method for Large Scale Isolation of Kidney Glomeruli from Mice
M. Molitch, R. DeFronzo, M. Franz, W. Keane, C. Mogensen, H. Parving, M. Steffes (2004)
Nephropathy in diabetes.Diabetes care, 27 Suppl 1
Xuehui Hong, Yang Xu, Xingfeng Qiu, Yuekun Zhu, Xing Feng, Z. Ding, Shifeng Zhang, Lifeng Zhong, Y. Zhuang, Chen Su, Xinya Hong, Jianchun Cai (2016)
MiR-448 promotes glycolytic metabolism of gastric cancer by downregulating KDM2BOncotarget, 7
Songyan Wang, Bing Li, Chunguang Li, W. Cui, Lining Miao (2015)
Potential Renoprotective Agents through Inhibiting CTGF/CCN2 in Diabetic NephropathyJournal of Diabetes Research, 2015
T. Tervaert, A. Mooyaart, K. Amann, A. Cohen, H. Cook, C. Drachenberg, F. Ferrario, A. Fogo, M. Haas, Emile Heer, K. Joh, L. Noël, J. Radhakrishnan, S. Seshan, I. Bajema, J. Bruijn (2010)
Pathologic classification of diabetic nephropathy.Journal of the American Society of Nephrology : JASN, 21 4
Vasantha Kolavennu, L. Zeng, Hui Peng, Yin Wang, Farhad Danesh (2008)
Targeting of RhoA/ROCK Signaling Ameliorates Progression of Diabetic Nephropathy Independent of Glucose ControlDiabetes, 57
F. Peng, Baifang Zhang, Dongcheng Wu, A. Ingram, B. Gao, J. Krepinsky (2008)
TGFbeta-induced RhoA activation and fibronectin production in mesangial cells require caveolae.American journal of physiology. Renal physiology, 295 1
S. Sanlioglu, Carleta Williams, L. Samavati, N. Butler, Guoshun Wang, P. McCray, T. Ritchie, G. Hunninghake, E. Zandi, J. Engelhardt (2001)
Lipopolysaccharide Induces Rac1-dependent Reactive Oxygen Species Formation and Coordinates Tumor Necrosis Factor-α Secretion through IKK Regulation of NF-κB*The Journal of Biological Chemistry, 276
M Takemoto, N Asker, H Gerhardt, A Lundkvist, BR Johansson, Y Saito, C Betsholtz (2002)
A new method for large scale isolation of kidney glomeruli from mice, 161
Daiji Kawanami, Keiichiro Matoba, Yasushi Kanazawa, Sho Ishizawa, T. Yokota, K. Utsunomiya (2011)
Thrombin induces MCP-1 expression through Rho-kinase and subsequent p38MAPK/NF-κB signaling pathway activation in vascular endothelial cells.Biochemical and biophysical research communications, 411 4
Keiichiro Matoba, Daiji Kawanami, Rina Okada, M. Tsukamoto, Jun Kinoshita, Tomoko Ito, Sho Ishizawa, Yasushi Kanazawa, T. Yokota, N. Murai, S. Matsufuji, J. Takahashi‐Fujigasaki, K. Utsunomiya (2013)
Rho-kinase inhibition prevents the progression of diabetic nephropathy by downregulating hypoxia-inducible factor 1α.Kidney international, 84 3
T. Leung, Xi Chen, E. Manser, L. Lim (1996)
The p160 RhoA-binding kinase ROK alpha is a member of a kinase family and is involved in the reorganization of the cytoskeletonMolecular and Cellular Biology, 16
Hongting Zheng, S. Whitman, Wei Wu, G. Wondrak, P. Wong, Deyu Fang, Donna Zhang (2011)
Therapeutic Potential of Nrf2 Activators in Streptozotocin-Induced Diabetic NephropathyDiabetes, 60
Hanshi Xu, L. Zeng, Hui Peng, Sheldon Chen, Jonathan Jones, T. Chew, M. Sadeghi, Y. Kanwar, Farhad Danesh (2006)
HMG-CoA reductase inhibitor simvastatin mitigates VEGF-induced "inside-out" signaling to extracellular matrix by preventing RhoA activation.American journal of physiology. Renal physiology, 291 5
Daiji Kawanami, Keiichiro Matoba, K. Utsunomiya (2016)
Signaling pathways in diabetic nephropathy.Histology and histopathology, 31 10
Y. Rikitake, Naotsugu Oyama, Chao-Yung Wang, K. Noma, M. Satoh, Hyung-Hwan Kim, J. Liao (2005)
Decreased Perivascular Fibrosis but Not Cardiac Hypertrophy in ROCK1+/− Haploinsufficient MiceCirculation, 112
N. Abdel-Wahab, B. Weston, T. Roberts, R. Mason (2002)
Connective tissue growth factor and regulation of the mesangial cell cycle: role in cellular hypertrophy.Journal of the American Society of Nephrology : JASN, 13 10
Toru Shimizu, N. Narang, Phetcharat Chen, Brian Yu, Maura Knapp, Jyothi Janardanan, John Blair, J. Liao (2017)
Fibroblast deletion of ROCK2 attenuates cardiac hypertrophy, fibrosis, and diastolic dysfunction.JCI insight, 2 13
BS Weston, NA Wahab, RM Mason (2003)
CTGF mediates TGF-beta-induced fibronectin matrix deposition by upregulating active alpha5beta1 integrin in human mesangial cells, 14
Keiichiro Matoba, Daiji Kawanami, M. Tsukamoto, Jun Kinoshita, Tomoko Ito, Sho Ishizawa, Yasushi Kanazawa, T. Yokota, N. Murai, S. Matsufuji, K. Utsunomiya (2014)
Rho-kinase regulation of TNF-α-induced nuclear translocation of NF-κB RelA/p65 and M-CSF expression via p38 MAPK in mesangial cells.American journal of physiology. Renal physiology, 307 5
B. Chaqour, Rude Yang, Q. Sha (2006)
Mechanical Stretch Modulates the Promoter Activity of the Profibrotic Factor CCN2 through Increased Actin Polymerization and NF-κB Activation*Journal of Biological Chemistry, 281
J. Cooper (1987)
Effects of cytochalasin and phalloidin on actinThe Journal of Cell Biology, 105
Ting Xu, Mengjie Wu, Jian-ying Feng, Xin-ping Lin, Z. Gu (2012)
RhoA/Rho kinase signaling regulates transforming growth factor-β1-induced chondrogenesis and actin organization of synovium-derived mesenchymal stem cells through interaction with the Smad pathway.International journal of molecular medicine, 30 5
Melina Livitsanou, Eleftheria Vasilaki, C. Stournaras, D. Kardassis (2018)
Modulation of TGFβ/Smad signaling by the small GTPase RhoB.Cellular signalling, 48
M. Kitamura, T. Sütö (1997)
TGF-beta and glomerulonephritis: anti-inflammatory versus prosclerotic actions.Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association, 12 4
Zhao-hui Feng, Xiao-hui Zhang, Jia-Qi Zhao, Jun-Ze Ma (2017)
Involvement of Rho-associated coiled-coil kinase signaling inhibition in TGF-β1/Smad2, 3 signal transduction in vitro.International journal of ophthalmology, 10 12
Wenjian Wang, Yin Wang, Jianyin Long, Jinrong Wang, S. Haudek, P. Overbeek, B. Chang, P. Schumacker, Farhad Danesh (2012)
Mitochondrial fission triggered by hyperglycemia is mediated by ROCK1 activation in podocytes and endothelial cells.Cell metabolism, 15 2
D. Gordin, Hetal Shah, T. Shinjo, R. St-Louis, Weier Qi, Kyoungmin Park, Samantha Paniagua, D. Pober, I-Hsien Wu, Vanessa Bahnam, Megan Brissett, Liane Tinsley, J. Dreyfuss, Hui Pan, Yutong Dong, M. Niewczas, P. Amenta, T. Sadowski, A. Kannt, H. Keenan, G. King (2019)
Characterization of Glycolytic Enzymes and Pyruvate Kinase M2 in Type 1 and 2 Diabetic NephropathyDiabetes Care, 42
Amy Banes-Berceli, S. Shaw, Guochuan Ma, M. Brands, D. Eaton, D. Stern, D. Fulton, R. Caldwell, M. Marrero (2006)
Effect of simvastatin on high glucose- and angiotensin II-induced activation of the JAK/STAT pathway in mesangial cells.American journal of physiology. Renal physiology, 291 1
Y. Shimizu, K. Dobashi, T. Sano, M. Yamada (2014)
Rock Activation in Lung of Idiopathic Pulmonary Fibrosis with Oxidative StressInternational Journal of Immunopathology and Pharmacology, 27
O. Sokolova, M. Naumann (2017)
NF-κB Signaling in Gastric CancerToxins, 9
Yong-chao Qiao, Yin-ling Chen, Yan-hong Pan, Wei Ling, F. Tian, Xiao-Xi Zhang, Hai-Lu Zhao (2017)
Changes of transforming growth factor beta 1 in patients with type 2 diabetes and diabetic nephropathyMedicine, 96
N. Wahab, N. Yevdokimova, B. Weston, T. Roberts, Xin Li, H. Brinkman, R. Mason (2001)
Role of connective tissue growth factor in the pathogenesis of diabetic nephropathy.The Biochemical journal, 359 Pt 1
Ji-won Park, Han-Sol Lee, Y. Lim, J. Paik, O. Kwon, Jung-hee Kim, I. Paryanto, Prasetyawan Yunianto, S. Choi, Sei-Ryang Oh, K. Ahn (2018)
Rhododendron album Blume extract inhibits TNF-α/IFN-γ-induced chemokine production via blockade of NF-κB and JAK/STAT activation in human epidermal keratinocytes.International journal of molecular medicine, 41 6
N. Wahab, D. Cox, Abi Witherden, R. Mason (2007)
Connective tissue growth factor (CTGF) promotes activated mesangial cell survival via up-regulation of mitogen-activated protein kinase phosphatase-1 (MKP-1).The Biochemical journal, 406 1
F. Ziyadeh (2004)
Mediators of Diabetic Renal Disease: The Case for TGF-β as the Major MediatorJournal of The American Society of Nephrology, 15
Hee-Jun Kim, Jae‐Gyu Kim, Mi‐Young Moon, Seol-Hye Park, Jae-Bong Park (2013)
IκB Kinase γ/Nuclear Factor-κB-Essential Modulator (IKKγ/NEMO) Facilitates RhoA GTPase Activation, which, in Turn, Activates Rho-associated Kinase (ROCK) to Phosphorylate IKKβ in Response to Transforming Growth Factor (TGF)-β1*The Journal of Biological Chemistry, 289
A. Gojo, K. Utsunomiya, Kanta Taniguchi, T. Yokota, Sho Ishizawa, Yasushi Kanazawa, H. Kurata, N. Tajima (2007)
The Rho-kinase inhibitor, fasudil, attenuates diabetic nephropathy in streptozotocin-induced diabetic rats.European journal of pharmacology, 568 1-3
Xi Xie, Jing Peng, Xiuting Chang, Kaipeng Huang, Juan Huang, Shaogui Wang, Xiaoyan Shen, Peiqing Liu, Heqing Huang (2013)
Activation of RhoA/ROCK regulates NF-κB signaling pathway in experimental diabetic nephropathyMolecular and Cellular Endocrinology, 369
D. Thumkeo, Jeongsin Keel, T. Ishizaki, Masaya Hirose, Kimiko Nonomura, H. Oshima, M. Oshima, M. Taketo, S. Narumiya (2003)
Targeted Disruption of the Mouse Rho-Associated Kinase 2 Gene Results in Intrauterine Growth Retardation and Fetal DeathMolecular and Cellular Biology, 23
YC Qiao, YL Chen, YH Pan, W Ling, F Tian, XX Zhang, HL Zhao (2017)
Changes of transforming growth factor beta 1 in patients with type 2 diabetes and diabetic nephropathy: a PRISMA-compliant systematic review and meta-analysis, 96
Keiichiro Matoba, Daiji Kawanami, Yosuke Nagai, Yusuke Takeda, Tomoyo Akamine, Sho Ishizawa, Yasushi Kanazawa, T. Yokota, K. Utsunomiya (2017)
Rho-Kinase Blockade Attenuates Podocyte Apoptosis by Inhibiting the Notch Signaling Pathway in Diabetic NephropathyInternational Journal of Molecular Sciences, 18
Meenalakshmi Mariappan (2012)
Signaling Mechanisms in the Regulation of Renal Matrix Metabolism in DiabetesExperimental Diabetes Research, 2012
Yasuhiko Ito, J. Aten, R. Bende, B. Oemar, T. Rabelink, J. Weening, R. Goldschmeding (1998)
Expression of connective tissue growth factor in human renal fibrosis.Kidney international, 53 4
R. Komers, T. Oyama, Douglas Beard, C. Tikellis, Bei Xu, Daniel Lotspeich, S. Anderson (2011)
Rho kinase inhibition protects kidneys from diabetic nephropathy without reducing blood pressure.Kidney international, 79 4
B. Weston, N. Wahab, R. Mason (2003)
CTGF Mediates TGF-– Induced Fibronectin Matrix Deposition by Upregulating Active 5 1 Integrin in Human Mesangial Cells
T. Khera, John Martin, S. Riley, R. Steadman, A. Phillips (2006)
Glucose enhances mesangial cell apoptosisLaboratory Investigation, 86
F. Miralles, G. Posern, A. Zaromytidou, R. Treisman (2003)
Actin Dynamics Control SRF Activity by Regulation of Its Coactivator MALCell, 113
Guang-Ping Sun, M. Kohno, P. Guo, Y. Nagai, K. Miyata, Yu Fan, S. Kimura, H. Kiyomoto, K. Ohmori, De-tian Li, Y. Abe, A. Nishiyama (2006)
Involvements of Rho-kinase and TGF-beta pathways in aldosterone-induced renal injury.Journal of the American Society of Nephrology : JASN, 17 8
I. Loeffler, G. Wolf (2014)
Transforming growth factor-β and the progression of renal disease.Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association, 29 Suppl 1
F. Peng, Dongcheng Wu, B. Gao, A. Ingram, Baifang Zhang, K. Chorneyko, R. McKenzie, J. Krepinsky (2008)
RhoA/Rho-Kinase Contribute to the Pathogenesis of Diabetic Renal DiseaseDiabetes, 57
Xiaoming Wang, Xiaohong Zhao, Ting Feng, G. Jin, Zhenjiang Li (2016)
Rutin Prevents High Glucose-Induced Renal Glomerular Endothelial Hyperpermeability by Inhibiting the ROS/Rhoa/ROCK Signaling PathwayPlanta Medica, 82
Weier Qi, H. Keenan, Qian Li, A. Ishikado, A. Kannt, T. Sadowski, M. Yorek, I-Hsien Wu, S. Lockhart, L. Coppey, A. Pfenninger, C. Liew, G. Qiang, Alison Burkart, Stephanie Hastings, D. Pober, C. Cahill, M. Niewczas, William Israelsen, Liane Tinsley, I. Stillman, P. Amenta, E. Feener, M. Heiden, R. Stanton, George King (2017)
Pyruvate kinase M2 activation may protect against the progression of diabetic glomerular pathology and mitochondrial dysfunctionNature Medicine, 23
The small GTPase Rho and its effector Rho kinase (ROCK) are involved in the pathogenesis of diabetic kidney disease. Rho kinase has two isoforms: ROCK1 and ROCK2. However, it remains unclear which is mainly involved in the progression of diabetic glomerulosclerosis and the regulation of profibrotic mediators. Glomeruli isolated from type 2 diabetic db/db mice demonstrated increased gene expression of transforming growth factor (TGF)-β and its downstream profibrotic mediators. Chemical inhibition of ROCK suppressed the expression of profibrotic mediators in both isolated glomeruli and cultured mesangial cells. An investigation of mechanisms underlying this observation revealed activated ROCK functions through the phosphorylation of JNK and Erk and the nuclear translocation of NF-κB via actin dynamics. Knockdown by siRNA against ROCK1 and ROCK2 showed that ROCK2 but not ROCK1 controls this fibrotic machinery. Further in vivo experiments showed that ROCK2 activity in the renal cortex of db/db mice was elevated compared with control db/m mice. Importantly, oral administration of ROCK2 inhibitor attenuated renal ROCK2 activity, albuminuria, and glomerular fibrosis in db/db mice. These observations indicate that ROCK2 is a key player in the development of diabetic renal injury. Glomerular ROCK2 may be a potential therapeutic target for the treatment of diabetic kidney disease.
American Journal of Physiology-Renal Physiology – The American Physiological Society
Published: Oct 1, 2019
Read and print from thousands of top scholarly journals.
Already have an account? Log in
Bookmark this article. You can see your Bookmarks on your DeepDyve Library.
To save an article, log in first, or sign up for a DeepDyve account if you don’t already have one.
Copy and paste the desired citation format or use the link below to download a file formatted for EndNote
Access the full text.
Sign up today, get DeepDyve free for 14 days.
All DeepDyve websites use cookies to improve your online experience. They were placed on your computer when you launched this website. You can change your cookie settings through your browser.